The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Once weekly selinexor, carfilzomib, and dexamethasone (XKd) in carfilzomib nonrefractory multiple myeloma (MM) patients.
 
Cristina Gasparetto
Leadership - Celgene
Consulting or Advisory Role - Abbvie/Genentech; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi
Speakers' Bureau - GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
Travel, Accommodations, Expenses - Celgene; Karyopharm Therapeutics
 
Gary J. Schiller
Stock and Other Ownership Interests - Amgen; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis; Ono Pharmaceutical
Speakers' Bureau - Amgen; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, a Gilead company; Sanofi; Stemline Therapeutics
Research Funding - Abbvie; Actinium Pharmaceuticals; Actuate Therapeutics; Agios; Amgen; Arog; Astellas Pharma; Bristol-Myers Squibb/Celgene; Celator; Constellation Pharmaceuticals; Daiichi Sankyo; Deciphera; Delta-Fly Pharma; ElevateBio; FORMA Therapeutics; Fujifilm; Gamida Cell; Genentech/Roche; Geron; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Mateon Therapeutics; Novartis; Onconova Therapeutics; Ono Pharmaceutical; Pfizer; PrECOG; REGiMMUNE; Samus Therapeutics; Sangamo Bioscience; Sanofi; Sellas Life Sciences; Stemline Therapeutics; Takeda; Tolero Pharmaceuticals; Trovagene
 
Sascha Tuchman
Consulting or Advisory Role - Caelum Biosciences; Celgene; Karyopharm Therapeutics; Oncopeptides; Sanofi
Speakers' Bureau - Celgene
Research Funding - Celgene; Janssen; Karyopharm Therapeutics; Sanofi
 
Natalie Scott Callander
Research Funding - Cellectar
 
Muhamed Baljevic
Honoraria - Cardinal Health; Coleman Research; Curio Science; Gerson Lehrman Group; Guidepoint Global; Medicom Worldwide; National Cancer Care Network
Consulting or Advisory Role - Bristol-Myers Squibb; Karyopharm Therapeutics; Oncopeptides
 
Suzanne Lentzsch
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Caelum Biosciences; Celularity; GlaxoSmithKline; Janssen; Sanofi; Sorrento Therapeutics; Takeda
Speakers' Bureau - Clinical Care Options/NCCN; PeerView
Research Funding - Karyopharm Therapeutics; Sanofi
Patents, Royalties, Other Intellectual Property - Patent 11-1F4 mAb for use in AL Amyloidosis
Travel, Accommodations, Expenses - Janssen
 
Adriana C. Rossi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen
 
Rami Kotb
Stock and Other Ownership Interests - Karyopharm Therapeutics
Honoraria - Akcea Therapeutics; Amgen; Bristol-Myers Squibb; Janssen; Merck; Sanofi; Takeda
Consulting or Advisory Role - Akcea Therapeutics; Amgen; Bristol-Myers Squibb; Janssen; Merck; Sanofi; Takeda
Research Funding - Merck; Sanofi
 
Darrell White
No Relationships to Disclose
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Christine Chen
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis
Research Funding - Gilead Sciences
 
Heather J. Sutherland
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genzyme; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
 
Sumit Madan
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Harpoon; Janssen; Karyopharm Therapeutics; Sanofi
 
Richard LeBlanc
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb
 
Michael Sebag
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Ortho; Karyopharm Therapeutics; Novartis; Takeda
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Patent but with no associated royalties or profit
 
Christopher P. Venner
No Relationships to Disclose
 
Noa Biran
Honoraria - Bristol-Myers Squibb/Celgene; Curio Science; Janssen; Karyopharm Therapeutics; Physicans' Education Resource; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Sanofi
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Janssen; Sanofi
Research Funding - Bristol-Myers Squibb/Celgene; Janssen; Karyopharm Therapeutics; Merck
 
Dane Van Domelen
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Brea Lipe
Consulting or Advisory Role - Amgen; celgene; GlaxoSmithKline
Research Funding - Amgen (Inst); Celgene (Inst); cellectar (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Seagen (Inst)